today announced that the U.S. Food and Drug Administration (FDA) has approved COBENFYâ„¢ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.
World Heart Day is an international event observed annually on September 29 to raise awareness about cardiovascular diseases (CVDs) and promote heart health globally. It serves as a reminder for ...
The label also alerts patients that the drug is associated with urinary retention, increased heart rate and swelling in the face in rare cases; the medication is not recommended for people with a ...
Sept 27 (Reuters) - The U.S. Food and Drug Administration approved GE ... tracers to asses how well blood flows to the muscle of the heart. The 3D images of the tracer's distribution can then ...
It’s called Cobenfy, and it’s the first new drug for the mental health condition to be successfully developed in over 70 years. Cobenfy, now FDA-approved, is unique because it targets the ...
The first schizophrenia medication in decades with a new mechanism of action won US regulatory approval today. The approval offers the hope of an antipsychotic that would be more effective and ...
Opens in a new tab or window The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for ... increase in heart rate ...
Dupixent is already a blockbuster therapy for a range of immune-mediated diseases, but the Food and Drug Administration’s approval of the drug for chronic obstructive pulmonary disease greatly ...
A year ago, life for many people in the UK with attention deficit hyperactivity disorder (ADHD) became unpredictable and disorientating as their medications suddenly became scarce. They were told ...
As expected, the PlayStation 5 Pro – 30th Anniversary Limited Edition BundIe sold out in seconds, and already scalpers have uploaded their listings with enormous mark-ups in price. Pre-orders ...
The drug received accelerated approved in the U.S. in 2019, requiring further trials to confirm the benefits. In July, the European Medicines Agency posted online concerns, opens new tab about ...
Image Source : PTI The image has been used for representative purposes only. The Central Drug Standards Control Organisation (CDSCO) has flagged more than 50 drugs as "Not of Standard Quality (NSQ)".
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback